(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S.

Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...

"Most vaccines are not 100% effective, so you can see vaccine failures, but having vaccine failures doesn't mean the vaccine ...

FDA commissioner Marty Makary told FDA staff in an email that Prasad, “brings a great set of skills, energy, and competence ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

The Department of Health and Human Services' mass dismissals of workers who release government records "raise grave transparency, accountability, and privacy concerns," Oregon Sen. Ron Wyden said ...

In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. | GSK had expected to secure an FDA ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.

In this episode of Denatured BioSpace's head of insights Lori Ellis discusses the public health consequences of vaccine ...